CI build for yosemitev2

[Velumani T-ERS,HCLTech]

Classification: Public

Thanks Patrick for the update and enabling CI for yv2.

Regards,
Velu

-----Original Message-----
From: Patrick Williams <patrick at stwcx.xyz>
Sent: Friday, April 23, 2021 6:51 PM
To: Andrew Geissler <geissonator at gmail.com>
Cc: openbmc at lists.ozlabs.org; bradleyb at fuzziesquirrel.com; Velumani T-ERS,HCLTech <velumanit at hcl.com>; Patrick Williams <patrickw3 at fb.com>
Subject: Re: CI build for yosemitev2

On Fri, Jan 15, 2021 at 07:26:13AM -0600, Patrick Williams wrote:
> On Sun, Jan 03, 2021 at 07:27:06PM -0600, Andrew Geissler wrote:
> > > On Dec 21, 2020, at 9:32 AM, Velumani T-ERS,HCLTech <velumanit at hcl.com> wrote:
> > > Could you please help us to add the Yosemitev2 machine in the CI build verification.
>
> > 2) Donate a jenkins compute node to openbmc CI
>
> Facebook will allocate a few compute nodes to the Jenkins pool.
> Andrew, I'll work with you to get them online and integrated with
> Jenkins.  Once that is done, we can enable Yv2?

I wanted to follow up and let everyone know that this work effort is done and Yv2 is now enabled in CI.  Facebook is currently contributing 4 pretty fast machines to the Jenkins pool.

--
Patrick Williams
::DISCLAIMER::
________________________________
The contents of this e-mail and any attachment(s) are confidential and intended for the named recipient(s) only. E-mail transmission is not guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or may contain viruses in transmission. The e mail and its contents (with or without referred errors) shall therefore not attach any liability on the originator or HCL or its affiliates. Views or opinions, if any, presented in this email are solely those of the author and may not necessarily reflect the views or opinions of HCL or its affiliates. Any form of reproduction, dissemination, copying, disclosure, modification, distribution and / or publication of this message without the prior written consent of authorized representative of HCL is strictly prohibited. If you have received this email in error please delete it and notify the sender immediately. Before opening any email and/or attachments, please check them for viruses and other defects.
________________________________